迈克生物：“血型鉴定及不规则抗体筛查质控品”取得产品注册证书

Core Viewpoint - The company has received a medical device registration certificate for a new product, which is expected to enhance its market competitiveness and operational performance [1] Group 1 - The product is a "Blood Type Identification and Irregular Antibody Screening Quality Control Product" [1] - This new quality control product is designed to monitor the stability of laboratory testing systems and improve testing quality [1] - The registration certificate enriches the company's product portfolio, aiding in market expansion [1]